MDT
$85.51-1.81%
as of close, Oct 7, 2026
☾ AH $85.51 -1.81%
Medtronic plc.Stock · HealthcareS&P 500 Equal Weight 0.2%S&P 500 0.2%US Stock Market 0.1%Russell 3000 0.1%
MDT financial statements
The full income statement, balance sheet, and cash-flow statement for Medtronic plc. (MDT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-07 1.28B2024-10 1.28B2025-01 1.28B2025-04 1.28B2025-07 1.28B2025-10 1.28B2026-01 1.28B2026-04 1.28B2026-07 1.28B-0.3% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|---|
| Income Statement | as ofApr 24 ’26 | as ofApr 25 ’25 | as ofApr 26 ’24 | as ofApr 28 ’23 | as ofApr 29 ’22 | as ofApr 30 ’21 | |
| Revenue | 36.4B+8.4% | 33.5B+3.6% | 32.4B+3.6% | 31.2B-1.4% | 31.7B+5.2% | 30.1B+4.2% | |
| Cost of revenue | 12.7B+9.4% | 11.6B+3.7% | 11.2B+4.6% | 10.7B+5.7% | 10.1B-3.2% | 10.5B+11.2% | |
| Research & development | 2.87B+5.2% | 2.73B-0.1% | 2.73B+1.4% | 2.70B-1.8% | 2.75B+10.1% | 2.49B+6.9% | |
| Selling, general & administrative | 11.8B+8.6% | 10.8B+1.1% | 10.7B+3.1% | 10.4B+1.2% | 10.3B+1.4% | 10.1B+0.4% | |
| Restructuring | — | — | 389M-39.9% | 647M+93.1% | 335M-37.8% | 539M+16.7% | |
| Amortization of intangibles | 1.77B-1.9% | 1.81B+6.7% | 1.69B-0.3% | 1.70B-2.0% | 1.73B-2.8% | 1.78B+1.5% | |
| Provision for credit losses | 136M+10.6% | 123M+36.7% | 90.0M+23.3% | 73.0M+25.9% | 58.0M-54.7% | 128M+29.3% | |
| Operating income | 6.47B+8.6% | 5.96B+15.8% | 5.14B-6.2% | 5.49B-4.6% | 5.75B+28.3% | 4.48B-6.4% | |
| Interest expense | 715M-1.9% | 729M+1.4% | 719M+13.1% | 636M+15.0% | 553M-40.2% | 925M-15.3% | |
| Net interest income | 383M-25.0% | 511M-14.4% | 597M+54.7% | 386M+107.5% | 186M | — | |
| Other non-operating income | 384M-4.5% | 402M-2.4% | 412M-20.0% | 515M+61.9% | 318M-5.4% | 336M-5.6% | |
| Pre-tax income | 6.14B+9.0% | 5.63B+16.4% | 4.84B-9.8% | 5.36B-2.8% | 5.52B+41.6% | 3.90B-3.9% | |
| Income tax | 1.30B+38.8% | 936M-17.4% | 1.13B-28.3% | 1.58B+246.5% | 456M+72.1% | 265M+135.3% | |
| 4.80B+3.0% | 4.66B+26.8% | 3.68B-2.2% | 3.76B-25.4% | 5.04B+39.7% | 3.61B-24.7% | ||
| Net income to non-controlling interest | 37.0M+27.6% | 29.0M+3.6% | 28.0M+7.7% | 26.0M+18.2% | 22.0M-8.3% | 24.0M+41.2% | |
| $3.73+3.3% | $3.61+30.8% | $2.76-2.1% | $2.82-24.4% | $3.73+40.2% | $2.66-24.9% | ||
| EPS (basic) | $3.75+3.3% | $3.63+31.0% | $2.77-2.1% | $2.83-24.5% | $3.75+39.9% | $2.68-24.9% | |
| Weighted-avg shares (basic) | 1.28B-0.3% | 1.29B-3.2% | 1.33B-0.2% | 1.33B-0.9% | 1.34B-0.2% | 1.34B+0.3% | |
| Weighted-avg shares (diluted) | 1.29B-0.1% | 1.29B-3.0% | 1.33B-0.2% | 1.33B-1.4% | 1.35B-0.2% | 1.35B+0.2% | |
| Dividends per share | $2.84+1.4% | $2.80+1.4% | $2.76+1.5% | $2.72+7.9% | $2.52+8.6% | $2.32+7.4% | |
| Balance Sheet | as ofApr 24 ’26 | as ofApr 25 ’25 | as ofApr 26 ’24 | as ofApr 28 ’23 | as ofApr 29 ’22 | as ofApr 30 ’21 | |
| 24.8B+4.1% | 23.8B+8.6% | 21.9B+1.2% | 21.7B-6.0% | 23.1B+2.3% | 22.5B+2.3% | ||
| Cash & equivalents | 1.95B-12.1% | 2.22B+72.7% | 1.28B-16.8% | 1.54B-58.5% | 3.71B+3.4% | 3.59B-13.2% | |
| Short-term investments | 7.27B+7.8% | 6.75B+0.4% | 6.72B+4.8% | 6.42B-6.5% | 6.86B-5.1% | 7.22B+6.1% | |
| Accounts receivable | 6.64B+2.0% | 6.51B+6.3% | 6.13B+2.2% | 6.00B+8.1% | 5.55B+1.6% | 5.46B+17.6% | |
| Inventory | 5.95B+8.7% | 5.48B+5.0% | 5.22B-1.4% | 5.29B+14.7% | 4.62B+7.0% | 4.31B+2.0% | |
| Other current assets | 2.97B+4.0% | 2.86B+10.6% | 2.58B+6.6% | 2.42B+4.6% | 2.32B+18.6% | 1.96B-11.5% | |
| 93.0B+1.5% | 91.7B+1.9% | 90.0B-1.1% | 90.9B-0.0% | 91.0B-2.3% | 93.1B+2.6% | ||
| Property, plant & equipment | 7.42B+8.5% | 6.84B+11.5% | 6.13B+10.1% | 5.57B+2.9% | 5.41B+3.7% | 5.22B+8.1% | |
| Operating lease right-of-use | 1.20B+8.8% | 1.10B+8.7% | 1.01B-2.8% | 1.04B+21.9% | 854M-14.4% | 998M+7.7% | |
| Goodwill | 42.6B+2.0% | 41.7B+1.8% | 41.0B-1.1% | 41.4B+2.3% | 40.5B-3.5% | 42.0B+5.3% | |
| Intangible assets | 10.1B-13.0% | 11.7B-11.8% | 13.2B-10.9% | 14.8B-4.8% | 15.6B-12.1% | 17.7B-6.9% | |
| Deferred tax assets | 3.94B-2.4% | 4.04B+10.5% | 3.66B+5.2% | 3.48B+2.2% | 3.40B+7.4% | 3.17B+11.9% | |
| Other non-current assets | 4.15B+15.7% | 3.58B-11.4% | 4.05B+2.2% | 3.96B+31.6% | 3.01B+23.1% | 2.44B+16.7% | |
| 11.7B-9.5% | 12.9B+19.4% | 10.8B+19.2% | 9.05B-27.0% | 12.4B+45.7% | 8.51B-17.9% | ||
| Accounts payable | 2.64B+8.0% | 2.45B+1.6% | 2.41B-9.5% | 2.66B+17.0% | 2.28B+8.1% | 2.11B+5.5% | |
| Short-term & current debt | 1.79B-37.8% | 2.87B+163.2% | 1.09B+5360.0% | 20.0M-99.5% | 3.74B-66.0% | 11.0B+296.3% | |
| Current lease liability | 198M+3.1% | 192M+4.9% | 183M+1.7% | 180M+7.8% | 167M-10.2% | 186M+8.8% | |
| Other current liabilities | 3.63B-1.3% | 3.68B+2.8% | 3.58B+0.0% | 3.58B+0.8% | 3.55B+2.2% | 3.48B+16.1% | |
| Finance lease liability (current) | 6.00M+0.0% | 6.00M+0.0% | 6.00M-14.3% | 7.00M+16.7% | 6.00M-33.3% | 9.00M+80.0% | |
| 43.0B-1.1% | 43.4B+9.8% | 39.6B+0.7% | 39.3B+2.7% | 38.3B-7.8% | 41.5B+4.2% | ||
| Long-term debt | 26.2B+2.1% | 25.6B+7.1% | 23.9B-1.7% | 24.3B+19.5% | 20.4B-22.8% | 26.4B+19.1% | |
| Non-current lease liability | 989M+7.7% | 918M+9.3% | 840M-3.3% | 869M+23.6% | 703M-15.2% | 829M+7.1% | |
| Operating lease liability (total) | 1.19B+7.1% | 1.11B+8.3% | 1.02B-2.4% | 1.05B+20.4% | 871M-14.2% | 1.01B+7.4% | |
| Finance lease liability | 54.0M+3.8% | 52.0M-5.5% | 55.0M-3.5% | 57.0M+1.8% | 56.0M-9.7% | 62.0M+37.8% | |
| Deferred tax liabilities | 362M-10.2% | 403M-21.7% | 515M-27.3% | 708M-19.9% | 884M-14.0% | 1.03B-12.4% | |
| Other non-current liabilities | 2.06B+16.2% | 1.77B+29.6% | 1.36B-21.0% | 1.73B+22.5% | 1.41B-19.7% | 1.76B+5.5% | |
| 49.5B+3.0% | 48.0B-4.4% | 50.2B-2.5% | 51.5B-2.0% | 52.6B+2.2% | 51.4B+1.4% | ||
| Common stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Additional paid-in capital | 20.9B+0.4% | 20.8B-9.9% | 23.1B-5.9% | 24.6B+0.1% | 24.6B-6.7% | 26.3B+0.6% | |
| Retained earnings | 32.6B+3.7% | 31.5B+3.5% | 30.4B+0.0% | 30.4B+0.5% | 30.3B+5.8% | 28.6B+1.6% | |
| Accumulated other comprehensive income | -4.10B+4.3% | -4.28B-29.1% | -3.32B+5.2% | -3.50B-54.5% | -2.27B+35.0% | -3.48B+2.1% | |
| Non-controlling interest | 609M+162.5% | 232M+12.6% | 206M+13.2% | 182M+6.4% | 171M-1.7% | 174M+28.9% | |
| Total equity incl. non-controlling | 50.1B+3.8% | 48.3B-4.3% | 50.4B-2.4% | 51.7B-2.0% | 52.7B+2.2% | 51.6B+1.4% | |
| Total liabilities & equity | 93.0B+1.5% | 91.7B+1.9% | 90.0B-1.1% | 90.9B-0.0% | 91.0B-2.3% | 93.1B+2.6% | |
| Common shares issued | 1.28B-0.1% | 1.28B-2.2% | 1.31B-1.5% | 1.33B+0.0% | 1.33B-1.1% | 1.35B+0.3% | |
| Common shares outstanding | 1.28B-0.1% | 1.28B-2.2% | 1.31B-1.5% | 1.33B+0.0% | 1.33B-1.1% | 1.35B+0.3% | |
| Shares outstanding (cover) | 1.28B-0.1% | 1.28B-0.1% | 1.28B-3.6% | 1.33B+0.1% | 1.33B-1.1% | 1.34B+0.2% | |
| Cash Flow | as ofApr 24 ’26 | as ofApr 25 ’25 | as ofApr 26 ’24 | as ofApr 28 ’23 | as ofApr 29 ’22 | as ofApr 30 ’21 | |
| 7.33B+4.1% | 7.04B+3.8% | 6.79B+12.4% | 6.04B-17.8% | 7.35B+17.7% | 6.24B-13.7% | ||
| Depreciation & amortization | 2.96B+3.4% | 2.86B+8.1% | 2.65B-1.9% | 2.70B-0.4% | 2.71B+0.2% | 2.70B+1.5% | |
| Intangible amortization | 1.77B-1.9% | 1.81B+6.7% | 1.69B-0.3% | 1.70B-2.0% | 1.73B-2.8% | 1.78B+1.5% | |
| Share-based compensation | 457M+6.5% | 429M+9.2% | 393M+10.7% | 355M-1.1% | 359M+4.4% | 344M+15.8% | |
| Deferred income taxes | 31.0M+109.1% | -339M+35.8% | -528M-108.7% | -253M+58.6% | -611M-32.5% | -461M+63.9% | |
| Change in inventory | 404M+38.4% | 292M+110.1% | 139M-85.2% | 939M+67.7% | 560M+817.9% | -78.0M-113.5% | |
| -2.93B-51.5% | -1.94B+18.1% | -2.37B+32.3% | -3.49B-110.5% | -1.66B+42.1% | -2.87B+10.5% | ||
| Capital expenditure | 1.90B+2.4% | 1.86B+17.1% | 1.59B+8.8% | 1.46B+6.7% | 1.37B+1.0% | 1.35B+11.7% | |
| Free cash flow | 5.43B+4.6% | 5.18B-0.3% | 5.20B+13.5% | 4.58B-23.4% | 5.98B+22.4% | 4.88B-18.9% | |
| Acquisitions | 406M+314.3% | 98.0M-53.6% | 211M-88.7% | 1.87B+1951.6% | 91.0M-90.8% | 994M+103.7% | |
| Purchases of investments | 8.72B+6.1% | 8.23B+6.2% | 7.75B+3.1% | 7.51B-24.0% | 9.88B-16.3% | 11.8B+7.0% | |
| Sales/maturities of investments | 8.11B-4.6% | 8.49B+14.2% | 7.44B+1.3% | 7.34B-24.2% | 9.69B-14.6% | 11.3B+18.5% | |
| Other investing activities | 4.00M-98.4% | 249M-4.6% | 261M+6625.0% | -4.00M-140.0% | 10.0M-81.5% | 54.0M+45.9% | |
| -4.75B-8.9% | -4.36B+2.0% | -4.45B+10.3% | -4.96B+7.0% | -5.34B-29.0% | -4.14B+1.5% | ||
| Long-term debt issued | 1.75B-45.6% | 3.21B | 0.00-100.0% | 5.41B | 0.00-100.0% | 7.17B+28.8% | |
| Long-term debt repaid | 2.93B | 0.00 | 0.00-100.0% | 6.01B+601100.0% | 1.00M-100.0% | 7.37B+20.6% | |
| Common stock issued | 516M+1.6% | 508M+78.9% | 284M | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 1.03B-68.0% | 3.23B+51.3% | 2.14B+231.5% | 645M-74.6% | 2.54B+290.2% | 652M-50.8% | |
| Dividends paid | 3.64B+1.4% | 3.59B-2.1% | 3.67B+1.4% | 3.62B+6.9% | 3.38B+8.4% | 3.12B+7.8% | |
| Other financing activities | 44.0M+123.9% | -184M-6033.3% | -3.00M+99.3% | -409M-350.9% | 163M+160.8% | -268M-230.9% | |
| FX effect on cash | 85.0M-54.8% | 188M+181.7% | -230M-194.7% | 243M+205.2% | -231M-207.4% | 215M+350.0% | |
| Net change in cash | -269M-128.8% | 934M+460.6% | -259M+88.1% | -2.17B-1894.2% | 121M+122.1% | -547M-116.2% | |
| Interest paid | 774M+1.6% | 762M-7.7% | 826M+36.3% | 606M+12.2% | 540M-7.2% | 582M-9.5% | |
| Income taxes paid | 1.94B+6.8% | 1.82B+12.1% | 1.62B+4.8% | 1.55B+55.4% | 996M-20.3% | 1.25B+42.4% | |
| Valuation Ratios | as ofApr 24 ’26 | as ofApr 25 ’25 | as ofApr 26 ’24 | as ofApr 28 ’23 | as ofApr 29 ’22 | as ofApr 30 ’21 | |
| Market cap | 107B-1.1% | 108B+5.5% | 102B-15.5% | 121B-12.7% | 139B-21.2% | 176B+32.1% | |
| P/E | 22.2×-4.0% | 23.1×-16.8% | 27.8×-13.6% | 32.2×+17.0% | 27.5×-43.6% | 48.8×+75.4% | |
| P/S | 2.9×-8.8% | 3.2×+1.8% | 3.2×-18.5% | 3.9×-11.5% | 4.4×-25.1% | 5.8×+26.8% | |
| P/B | 2.2×-4.0% | 2.2×+10.3% | 2.0×-13.4% | 2.4×-10.9% | 2.6×-22.9% | 3.4×+30.3% | |
| P/FCF | 19.7×-5.5% | 20.8×+5.8% | 19.7×-25.6% | 26.4×+13.9% | 23.2×-35.6% | 36.0×+62.8% | |
| Earnings yield | 4.5%+4.1% | 4.3%+20.3% | 3.6%+15.8% | 3.1%-14.5% | 3.6%+77.3% | 2.0%-43.0% | |
| FCF yield | 5.1%+5.8% | 4.8%-5.5% | 5.1%+34.4% | 3.8%-12.2% | 4.3%+55.3% | 2.8%-38.6% | |
| Dividend yield | 3.4%+2.5% | 3.3%-3.9% | 3.5%+15.7% | 3.0%+23.9% | 2.4%+36.3% | 1.8%-18.5% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
One company, more than one SEC registrant: these statements were filed by Medtronic Inc until Jan 27, 2015 and by Medtronic plc since.
About this data
Source: MDT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MDT filings on SEC EDGAR → Not investment advice.